Background illustration for clinical trials search

Influenza Clinical Trials

Browse 153 Influenza clinical trials enrolling across the United States and Canada. 50 people applied to Influenza studies last month. Search by city or state to find one near you.

Filter
1

AeviceMD for Detection of Wheeze in Pediatric and Adult Populations

for
Subject Presenting Wheeze, Asthma, Bronchial Disease,
Location: The Bronx NY
Sponsor: Aevice Health Pte. Ltd.

Sex: All

Age: 3+

Code: NCT06691971

Recruiting

Measures of Respiratory Health Registry

for
Respiratory Disease, Cystic Fibrosis
Location: Vancouver
Sponsor: University of British Columbia

Sex: All

Age: 0 - 70+

Code: NCT05501587

Recruiting

Pomalidomide and Nivolumab in People With Virus-Associated Malignancies With or Without HIV

for
Viral Associated Malignancies, Kaposi Sarcoma,
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 70+

Code: NCT04902443

Phase 1, Recruiting

Safety and Pharmacokinetics Study of Human Monoclonal Antibody (FGI-101-1A6)

for
Influenza
Location: Baltimore MD
Sponsor: Functional Genetics Inc.

Sex: All

Age: 18 - 45

Code: NCT01299142

Phase 1, Recruiting

Bifidobacterium Lactis HN019 Supplementation for Prevention of Influenza Infection in Healthy Adults

for
Influenza
Location: Coral Gables FL, Rochester MI
Sponsor: Fonterra Research Centre

Sex: All

Age: 18 - 60

Code: NCT01258842

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

National Vaccine Adverse Event Reporting Survey and Etiology

for
COVID-19, Vaccine Adverse Reaction, Vaccine Reaction,
Location: Northglenn CO
Sponsor: Neuroganics LLC

Sex: All

Age: 5 - 70+

Code: NCT05095844

Recruiting

Rapid Vaccination of Hard-To-Reach Populations

for
Influenza
Location: New York NY
Sponsor: The New York Academy of Medicine

Sex: All

Age: 18+

Code: NCT00155974

Recruiting

The DETECT(Digital Engagement & Tracking for Early Control, & Treatment) Study

for
Influenza, Virus
Location: San Diego CA
Sponsor: Scripps Translational Science Institute

Sex: All

Age: 18+

Code: NCT04336020

Recruiting

Woodsmoke Exposure, Influenza Infection, and Nasal Immunity

for
Smoke Exposure, Influenza
Location: Chapel Hill NC
Sponsor: University of North Carolina, Chapel Hill

Sex: All

Age: 18 - 49

Code: NCT06841913

Recruiting

Study to Assess Safety and Immunogenicity of an Egg-based H5N8 Influenza Vaccine at Multiple Dose Levels Adjuvanted With Matrix-M in Healthy Participants 18 Years of Age and Above.

for
Healthy Volunteers, Influenza
Location: Charlottesville VA, Rochester NY, Coral Gables FL,
Sponsor: Sanofi

Sex: All

Age: 18+

Code: NCT07779408

Phase 1, Phase 2, Recruiting

Airway Remodeling and Rhinovirus in Asthmatics

for
Asthma, Respiratory Disease
Location: Calgary
Sponsor: University of Calgary

Sex: All

Age: 18 - 65

Code: NCT05775952

Recruiting

Effect of Drain Care on Infection Rate and Quality of Life in Implant-Based Breast Reconstruction.

for
Infections, Quality of Life
Location: Columbia MO
Sponsor: University of Missouri-Columbia

Sex: Female

Age: 18 - 70+

Code: NCT05846438

Recruiting

Does a Safety Difference Exist Between IV Push and IV Piggyback Antibiotics?

for
Infection
Location: Las Vegas NV
Sponsor: University Medical Center of Southern Nevada

Sex: All

Age: 18+

Code: NCT03360617

Recruiting

What is influenza?

Influenza, or flu, is a contagious respiratory infection caused by influenza viruses that spread through coughs, sneezes, and contaminated surfaces. It comes on fast with fever, aches, cough, and exhaustion, and for most people passes within a week or two, but it sends hundreds of thousands of Americans to the hospital in a typical season and is most dangerous for people over 65, young children, pregnant women, and people with heart, lung, or immune conditions. Flu viruses change constantly, which is why the vaccine is reformulated every year and why protection from one season does not carry over to the next.

Antiviral medicines shorten the illness if started within the first two days, and vaccination remains the main way to prevent severe disease. The first mRNA flu vaccine was approved in 2026, and researchers are working toward a universal vaccine that would not need yearly updates. COVID-19 is studied separately on our COVID-19 clinical trials page.

Article preview image

Interested in learning more about flu treatment? Read our guide: Flu Symptoms, Treatment, and Vaccines Explained

Rethinking Influenza: What the Latest Research Shows

Types of influenza clinical trials

Do influenza clinical trials only happen during flu season?

Who can participate in influenza clinical trials?

Do influenza trial participants get paid?

How to enroll in an influenza clinical trial